Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Latest Posted May 30, 2024
Young Living Essential Oils Agrees to Pay $5 Million to Settle Lawsuit
Young Living Essential Oils has agreed to pay up to $5 million to settle a class action lawsuit that charged the company with promoting its essential oils to reduce stress and anxiety, improve sleep, and other health-related claims without reliable scientific evidence.
The lawsuit also alleged that Young Living marketed its lavender, peppermint, and other essential oils as “therapeutic grade,” without providing evidence to support this claim, citing a ruling by the National Advertising Review Board in November 2020 that Young Living should discontinue use of this term because it was “unsupported.” At that time, Young Living agreed to comply and permanently discontinue the claim that its products are therapeutic. The company was warned by the FDA in 2022 for making claims its products could treat seasonal allergies, kidney stones, and other health conditions.
[See ConsumerLab’s Lavender and Tea Tree Essential Oils Review for tests of products and our Top Picks among essential oils. The Review also discusses the clinical evidence for essential oils for anxiety, sleep, pain, and other conditions.]
As part of the settlement agreement, consumers who purchased Young Living essential oils for personal use between January 1, 2017, through April 25, 2024 are eligible to receive a refund of up to $2 per product up to a maximum of $20. Consumers who wish to submit a claim must do so by June 24, 2024.
For more information, use the link below.
Class Action Settlement: MacNaughton, et al. v. Young Living Essential Oils, LC
See related recalls and warnings:
Young Living Warned for Promoting Essential Oils to Treat Seasonal Allergies, Kidney Stones & More
Sellers of Essential Oils Warned for Claiming to Treat Ebola, Other Diseases
Complaint Submitted to FTC for doTerra Essential Oil COVID Claims
The lawsuit also alleged that Young Living marketed its lavender, peppermint, and other essential oils as “therapeutic grade,” without providing evidence to support this claim, citing a ruling by the National Advertising Review Board in November 2020 that Young Living should discontinue use of this term because it was “unsupported.” At that time, Young Living agreed to comply and permanently discontinue the claim that its products are therapeutic. The company was warned by the FDA in 2022 for making claims its products could treat seasonal allergies, kidney stones, and other health conditions.
[See ConsumerLab’s Lavender and Tea Tree Essential Oils Review for tests of products and our Top Picks among essential oils. The Review also discusses the clinical evidence for essential oils for anxiety, sleep, pain, and other conditions.]
As part of the settlement agreement, consumers who purchased Young Living essential oils for personal use between January 1, 2017, through April 25, 2024 are eligible to receive a refund of up to $2 per product up to a maximum of $20. Consumers who wish to submit a claim must do so by June 24, 2024.
For more information, use the link below.
Class Action Settlement: MacNaughton, et al. v. Young Living Essential Oils, LC
See related recalls and warnings:
Young Living Warned for Promoting Essential Oils to Treat Seasonal Allergies, Kidney Stones & More
Sellers of Essential Oils Warned for Claiming to Treat Ebola, Other Diseases
Complaint Submitted to FTC for doTerra Essential Oil COVID Claims
Other Recent Recalls & Warnings
FDA Warns Seller of Unauthorized COVID-19 Tests
July 14, 2022
FDA Warns Company Selling Supplements with Dangerous Steroid-like Substances
July 14, 2022
FDA Warns Sellers of Tainted Honey-Based Sexual Enhancement Products
July 13, 2022
Vegan Protein Powder Recalled
July 06, 2022
Two Companies Banned From Selling Supplements to Treat Heart Disease, Neuropathy
July 06, 2022
FDA Warns Kratom Companies for Arthritis, Pain Relief Claims & More
July 06, 2022
Male Enhancement Supplements Sold on Amazon Recalled
July 01, 2022
FDA Warns Seller of Vision and Allergy Supplements
June 30, 2022
Built Brand Protein Bar Recalled Due to E. Coli Concern
June 17, 2022
Omega 3 Supplements Recalled Due to Undeclared Drug Ingredients
June 16, 2022
For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please visit the FDA MedWatch website.